Your browser doesn't support javascript.
loading
Retrospective Evaluation of Moderate Sedation Visits That Used Oral Meperidine and Hydroxyzine With Oral or Intranasal Midazolam.
Jain, Gaurav; Curran, Ronald; Jones, Robert S.
Afiliación
  • Jain G; Pediatric Dentistry Resident, Division of Pediatric Dentistry, Department of Surgical and Developmental Sciences, School of Dentistry, University of Minnesota, Minneapolis, Minn., USA.
  • Curran R; Clinical Professor, Division of Pediatric Dentistry, Department of Surgical and Developmental Sciences, School of Dentistry, University of Minnesota, Minneapolis, Minn., USA.
  • Jones RS; Associate Professor, Division of Pediatric Dentistry, Department of Surgical and Developmental Sciences, School of Dentistry, University of Minnesota, Minneapolis, Minn., USA.
J Dent Child (Chic) ; 90(3): 139-146, 2023 Nov 15.
Article en En | MEDLINE | ID: mdl-38123932
ABSTRACT

Purpose:

To examine the influence of substituting intranasal (IN) midazolam (MID) for oral (PO) MID, within the three-drug combination of meperidine (MEP), hydroxyzine (H) and MID, on sedation treatment outcomes.

Methods:

A retrospective, cross-sectional analysis examined patient variables and sedation outcomes in 508 pediatric dental patients sedated by single- and multi-drug sedation regimens (MEP-H; MEP-H-(PO)-MID; MEP-H-(IN)-MID; single-agent MID). The outcome assessment examined sedation visit effectiveness, sedation treatment completion, treatment time and medication administration to discharge time. Multivariable logistic regression analyses assessed predictive variables associated with sedation visit effectiveness.

Results:

Both three-drug combinations (MEP-H-(PO)-MID; MEP-H-(IN)-MID) were used for behavior guidance in children of a similar age (median age=7.1 and 6.5 years, respectively, for the two drug combinations) and weight (median weight = 23.7 and 23.5 kg, respectively, for the two drug combinations). These three-drug combinations had a higher likelihood of sedation effectiveness over the reference sedation regimen of single-agent midazolam (MEP-H-(PO)-MID adjusted odds ratio [OR] = 2.65; 95 percent confidence interval [95% CI]=1.09 to 6.45; P=0.032; and MEP-H-(IN)-MID OR=2.08; 95% CI=1.03 to 4.18; P=0.039). MEP-H-(IN)MID was associated with a shorter medication administration to discharge time for patients by 23 minutes (interquartile range [IQR]=9.5 to 34 minutes) compared to MEP-H-(PO) MID (P<0.05) while providing a comparable number of teeth treated (median=five). All sedation drug regimens, including MEP-H-(IN)MID, had high levels of oxygen saturation during all sedation appointments.

Conclusion:

Substituting IN for PO MID in MEP-H-MID was associated with a shorter total time to discharge while demonstrating comparable efficacy during sedation.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Midazolam / Anestesia Dental Límite: Child / Humans Idioma: En Revista: J Dent Child (Chic) Asunto de la revista: ODONTOLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Midazolam / Anestesia Dental Límite: Child / Humans Idioma: En Revista: J Dent Child (Chic) Asunto de la revista: ODONTOLOGIA / PEDIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos